IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx
IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.